Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.

Clinical genetics - 1 Oct 2007

Hartikainen J M, Kataja V, Pirskanen M, Arffman A, Ristonmaa U, Vahteristo P, Ryynänen M, Heinonen S, Kosma V-M, Mannermaa A

Abstract excerpt

Familial aggregation is thought to account for 5-10% of all breast cancer cases, and high penetrance breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 explain < or =20% of these. Hundreds of mutations among breast/ovarian cancer families have been found in these two genes. The mutati...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Finland
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Mass Screening

Share to Microsatellite Repeats

Share to Ovarian Neoplasms

Share to Prevalence

Source

Identifiers

PMID: 17850627
DOI: 10.1111/j.1399-0004.2007.00866.x

Genes

BRCA2
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17850627-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.PMID 17850627Read ↗

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.Semantic proximity Read ↗

Involvement of BRCA1 and BRCA2 in breast cancer in a western Finnish sub-population.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients.Semantic proximity Read ↗

Exclusion of large deletions and other rearrangements in BRCA1 and BRCA2 in Finnish breast and ovarian cancer families.Semantic proximity Read ↗

BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.Semantic proximity Read ↗

Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients.Semantic proximity Read ↗

Novel germline BRCA1 and BRCA2 mutations in Turkish women with breast and/or ovarian cancer and their relatives.Semantic proximity Read ↗

Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.Semantic proximity Read ↗

BRCA1 and BRCA2 mutation analysis in breast-ovarian cancer families from northeastern PolandSemantic proximity Read ↗

BRCA1/BRCA2 founder mutations and cancer risks: impact in the western Danish population.Semantic proximity Read ↗

Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.